SFC showed a trend towards improvement in FEV 1 compared to concurrent therapy with separate inhalers but it was not statistically significant ( P = 0.54; 95% CI, 0.00 to 0.08).
← all excerpts
Current trends in the treatment of asthma: focus on the simultaneous administration of salmeterol/fluticasone.
1
—
—